IMW 2019 | MRD in myeloma: an important surrogate for PFS

Bruno Paiva

Here, Bruno Paiva, PhD, from the University of Navarra Clinic, Pamplona, Spain, emphasizes how MRD assessment has become an appropriate surrogate for PFS in multiple myeloma. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video